NO140304C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 15alfa, 16alfa-methylen-4-oestren-17beta-oler - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 15alfa, 16alfa-methylen-4-oestren-17beta-oler

Info

Publication number
NO140304C
NO140304C NO528/73A NO52873A NO140304C NO 140304 C NO140304 C NO 140304C NO 528/73 A NO528/73 A NO 528/73A NO 52873 A NO52873 A NO 52873A NO 140304 C NO140304 C NO 140304C
Authority
NO
Norway
Prior art keywords
16alfa
15alfa
oestrene
17beta
oles
Prior art date
Application number
NO528/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO140304B (no
Inventor
Rudolf Wiechert
Hermann Steinbeck
Walter Elger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO140304B publication Critical patent/NO140304B/no
Publication of NO140304C publication Critical patent/NO140304C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO528/73A 1972-02-11 1973-02-09 Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 15alfa, 16alfa-methylen-4-oestren-17beta-oler NO140304C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (de) 1972-02-11 1972-02-11 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
NO140304B NO140304B (no) 1979-04-30
NO140304C true NO140304C (no) 1979-08-08

Family

ID=5836211

Family Applications (2)

Application Number Title Priority Date Filing Date
NO528/73A NO140304C (no) 1972-02-11 1973-02-09 Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 15alfa, 16alfa-methylen-4-oestren-17beta-oler
NO782754A NO143065C (no) 1972-02-11 1978-08-14 Kjemiske forbindelser for anvendelse i antikonsepsjonsmidler

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO782754A NO143065C (no) 1972-02-11 1978-08-14 Kjemiske forbindelser for anvendelse i antikonsepsjonsmidler

Country Status (29)

Country Link
JP (1) JPS5829317B2 (US07498051-20090303-C00003.png)
KR (1) KR780000156B1 (US07498051-20090303-C00003.png)
AT (1) AT327413B (US07498051-20090303-C00003.png)
AU (1) AU467306B2 (US07498051-20090303-C00003.png)
BE (1) BE795241A (US07498051-20090303-C00003.png)
CA (1) CA997753A (US07498051-20090303-C00003.png)
CH (2) CH590883A5 (US07498051-20090303-C00003.png)
CS (1) CS193019B2 (US07498051-20090303-C00003.png)
DD (1) DD102379A5 (US07498051-20090303-C00003.png)
DE (1) DE2207421C3 (US07498051-20090303-C00003.png)
DK (1) DK131037B (US07498051-20090303-C00003.png)
EG (1) EG10914A (US07498051-20090303-C00003.png)
ES (1) ES410933A1 (US07498051-20090303-C00003.png)
FI (1) FI52225C (US07498051-20090303-C00003.png)
FR (1) FR2181719B1 (US07498051-20090303-C00003.png)
GB (1) GB1425636A (US07498051-20090303-C00003.png)
GR (1) GR63160B (US07498051-20090303-C00003.png)
HU (1) HU165253B (US07498051-20090303-C00003.png)
IE (1) IE37266B1 (US07498051-20090303-C00003.png)
IL (1) IL41506A (US07498051-20090303-C00003.png)
NL (1) NL177217C (US07498051-20090303-C00003.png)
NO (2) NO140304C (US07498051-20090303-C00003.png)
PH (1) PH9370A (US07498051-20090303-C00003.png)
PL (1) PL81084B1 (US07498051-20090303-C00003.png)
RO (1) RO73527A (US07498051-20090303-C00003.png)
SE (3) SE403781B (US07498051-20090303-C00003.png)
SU (1) SU513628A3 (US07498051-20090303-C00003.png)
YU (1) YU35035B (US07498051-20090303-C00003.png)
ZA (1) ZA73944B (US07498051-20090303-C00003.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (de) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten

Also Published As

Publication number Publication date
GR63160B (en) 1979-09-25
YU35035B (en) 1980-06-30
SE426834B (sv) 1983-02-14
DK131037C (US07498051-20090303-C00003.png) 1975-10-20
JPS5829317B2 (ja) 1983-06-22
NO143065B (no) 1980-09-01
FI52225B (US07498051-20090303-C00003.png) 1977-03-31
DE2207421A1 (de) 1973-08-16
DE2207421B2 (de) 1980-07-24
DD102379A5 (US07498051-20090303-C00003.png) 1973-12-12
SE7514513L (sv) 1975-12-22
YU24373A (en) 1979-12-31
NL7301974A (US07498051-20090303-C00003.png) 1973-08-14
NO140304B (no) 1979-04-30
FR2181719A1 (US07498051-20090303-C00003.png) 1973-12-07
IE37266B1 (en) 1977-06-08
NO782754L (no) 1973-08-14
NO143065C (no) 1980-12-10
ES410933A1 (es) 1976-03-01
CS193019B2 (en) 1979-09-17
SE403781B (sv) 1978-09-04
AU467306B2 (en) 1975-11-27
FR2181719B1 (US07498051-20090303-C00003.png) 1975-11-21
IL41506A0 (en) 1973-04-30
BE795241A (fr) 1973-08-09
HU165253B (US07498051-20090303-C00003.png) 1974-07-27
ATA112473A (de) 1975-04-15
JPS4886856A (US07498051-20090303-C00003.png) 1973-11-15
AU5207673A (en) 1974-08-15
EG10914A (en) 1976-09-30
NL177217B (nl) 1985-03-18
CH590883A5 (US07498051-20090303-C00003.png) 1977-08-31
GB1425636A (en) 1976-02-18
AT327413B (de) 1976-01-26
IE37266L (en) 1973-08-11
PL81084B1 (US07498051-20090303-C00003.png) 1975-08-30
IL41506A (en) 1976-07-30
CA997753A (en) 1976-09-28
PH9370A (en) 1975-10-22
CH593995A5 (US07498051-20090303-C00003.png) 1977-12-30
DE2207421C3 (de) 1981-05-07
FI52225C (fi) 1977-07-11
NL177217C (nl) 1985-08-16
ZA73944B (en) 1973-11-28
KR780000156B1 (en) 1978-05-02
RO73527A (ro) 1982-02-01
SU513628A3 (ru) 1976-05-05
SE7713896L (sv) 1977-12-07
DK131037B (da) 1975-05-20
SE409329B (sv) 1979-08-13

Similar Documents

Publication Publication Date Title
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO140589C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive 3,4-dihydrokarbostyrilderivater
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO144743C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye penicillinderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO142865C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler
NO142033C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler
NO137782C (no) Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO138599C (no) Analogifremgangsmaate til fremstilling av nye, terapeutisk virksomme tienopyrimidinderivater
NO141648C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 2-oxazolinderivater
NO140348C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk aktive 3-(amino-2-hydroksypropoksy)-isoindolin-1-on-forbindelser
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO139088C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner
NO140858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 2,4-diamino-5-benzyl-pyrimidinderivater
NO142077C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider
NO138660C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 3-(piperazinalkyl)-2,4-kinazolindioner
FI49827C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi.
NO740411L (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on.
NO136840C (no) Analogifremgangsm}te til fremstilling av nye, terapeutisk aktive derivater av isoindolin
NO141555C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme dibenzocykloheptenkarboksamider
NO137548C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive n-difenylpropyl-propylendiaminer
NO140299C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner